|
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not
intended to be used as a source of information on on healthcare or medicines.
The web pages are not kept up to date and are for demonstration purposes only.
For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines
or the package leaflet of your medicine. For up-to-date information on other
healthcare topics, please consult the relevant reliable sources or an healthcare
expert, such as a physician etc.
|
BACK TO LIST |
|
|
|
|||||||||||||||||||||||||
| Test | 27-MAY-2023 | Reference Range | Unit |
|---|---|---|---|
| Hemoglobin A1c/Hemoglobin.total in Blood | 5.5 | 4.8 - 5.9 | % |
| Glucose [Mass/volume] in Blood | 65.6 L | 70 - 100 | mg/dL |
| Urea nitrogen [Mass/volume] in Blood | 10.9 | 7 - 20 | mg/dL |
| Creatinine [Mass/volume] in Blood | 0.8 | 0.6 - 1.3 | mg/dL |
| Calcium [Mass/volume] in Blood | 8.9 | 8.5 - 10.5 | mg/dL |
| Sodium [Moles/volume] in Blood | 139.3 | 135 - 145 | mmol/L |
| Potassium [Moles/volume] in Blood | 4.5 | 3.5 - 5.3 | mmol/L |
| Chloride [Moles/volume] in Blood | 106.1 | 98 - 107 | mmol/L |
| Carbon dioxide, total [Moles/volume] in Blood | 27.3 | 22 - 29 | mmol/L |
| Cholesterol [Mass/volume] in Serum or Plasma | 172.1 | 125 - 200 | mg/dL |
| Triglyceride [Mass/volume] in Serum or Plasma | 129.3 | 0 - 150 | mg/dL |
| Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay | 116.5 H | 0 - 100 | mg/dL |
| Cholesterol in HDL [Mass/volume] in Serum or Plasma | 29.7 L | 40 - 60 | mg/dL |
| Microalbumin/Creatinine [Mass Ratio] in Urine | 10.1 | 0 - 30 | mg/g |
| Conclusion and Recommendations based on this report and previous findings known to us |
|---|
| Most parameters are within normal limits. Notable findings include mildly low fasting glucose, low HDL cholesterol, and elevated LDL cholesterol, which increase cardiovascular risk. HbA1c is normal, indicating good long-term glucose control. Renal function and electrolytes are normal, and there is no evidence of microalbuminuria. Recommend addressing dyslipidemia and monitoring glucose. |